journal article·2026-12-31Open access

Coriandrum sativum improves prognosis in clear cell renal cell carcinoma by targeting NEK6 to modulate the immune microenvironment: a predictive study based on network pharmacology and multi-omics analysis

Jun Li, Yunfeng Zhang, Xing Wang, Penglin Zhang, Zuhuan Xu, Ruizhen Huang, Honglin Hu

Abstract

Coriandrum sativum L. (coriander) is a medicinal herb with diverse pharmacological properties, but its molecular mechanism in clear cell renal cell carcinoma (ccRCC) remains unclear. This study aimed to systematically investigate the underlying mechanisms of coriander in ccRCC by multi-omics analysis. Active compounds were screened using Traditional Chinese Medicine Systems Pharmacology (TCMSP) and predicted targets identified via SwissTargetPrediction (STP) and Similarity ensemble approach (SEA). Transcriptomic data from GSE53757 were analysed with WGCNA and intersected with coriander targets. Key genes were selected using LASSO, SVM, and random forest models. NEK6 was further analysed for clinical relevance, methylation, immune association, single-cell expression, molecular docking and molecular dynamics simulation. Fourteen coriander compounds were identified, yielding 22 potential ccRCC-related targets. NEK6 and PYGL were consistently selected by all machine learning algorithms. NEK6 was overexpressed in ccRCC and associated with better prognosis, promoter hypomethylation, and lower mutation rates. NEK6 expression correlated with immune infiltration, particularly macrophages, and was enriched in tumour and myeloid cells at the single-cell level. Molecular docking and molecular dynamics simulation revealed strong and stable binding of luteolin, quercetin, and chryseriol to NEK6. NEK6 may function as a prognostic and immune-regulatory biomarker in ccRCC. Coriander flavonoids could target NEK6 to modulate the immune microenvironment, providing new insight into plant-based therapeutic strategies for ccRCC.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Ferroptosis and cancer prognosis · Bioinformatics and Genomic Networks · Renal cell carcinoma treatment

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Urology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University

Funding

Jiangxi Provincial Natural Science Foundation Project

References (45)

Show source-provided references
1. 10.3322/caac.2183410.3322/caac.21834 ↗
2. 10.1200/JCO.2005.07.05510.1200/JCO.2005.07.055 ↗
3. 10.1093/annonc/mdz05610.1093/annonc/mdz056 ↗
4. 10.1038/nrdp.2017.910.1038/nrdp.2017.9 ↗
5. 10.1038/s41419-025-07848-x10.1038/s41419-025-07848-x ↗
6. 10.1016/j.foodchem.2024.14244410.1016/j.foodchem.2024.142444 ↗
7. 10.1038/s41598-025-03945-110.1038/s41598-025-03945-1 ↗
8. 10.1080/07391102.2022.213421010.1080/07391102.2022.2134210 ↗
9. 10.1016/j.jphotobiol.2016.08.00510.1016/j.jphotobiol.2016.08.005 ↗
10. 10.1002/jcb.2762510.1002/jcb.27625 ↗
11. 10.1007/s12094-022-02926-410.1007/s12094-022-02926-4 ↗
12. 10.1177/1533033825138283910.1177/15330338251382839 ↗
13. 10.2147/DDDT.S49244810.2147/DDDT.S492448 ↗
14. 10.1016/j.phymed.2025.15705110.1016/j.phymed.2025.157051 ↗
15. 10.1158/0008-5472.CAN-14-021010.1158/0008-5472.CAN-14-0210 ↗
16. 10.1093/nar/gkz83010.1093/nar/gkz830 ↗
17. 10.2217/epi-2017-011810.2217/epi-2017-0118 ↗
18. 10.1093/nar/gkaa40710.1093/nar/gkaa407 ↗
19. 10.1093/bioinformatics/btz21010.1093/bioinformatics/btz210 ↗
20. 10.1038/s41591-020-0860-110.1038/s41591-020-0860-1 ↗
21. 10.3389/fonc.2021.65925110.3389/fonc.2021.659251 ↗
22. 10.1073/pnas.210324011810.1073/pnas.2103240118 ↗
23. 10.1016/j.bioadv.2025.21460010.1016/j.bioadv.2025.214600 ↗
24. 10.1016/j.jep.2025.12086010.1016/j.jep.2025.120860 ↗
25. 10.1016/j.synbio.2024.12.00510.1016/j.synbio.2024.12.005 ↗
26. 10.1186/s12890-021-01617-010.1186/s12890-021-01617-0 ↗
27. 10.1615/CritRevEukaryotGeneExpr.202505744610.1615/CritRevEukaryotGeneExpr.2025057446 ↗
28. 10.1016/j.prp.2018.07.03010.1016/j.prp.2018.07.030 ↗
29. 10.1080/15384047.2018.148088810.1080/15384047.2018.1480888 ↗
30. 10.1016/j.biopha.2023.11442610.1016/j.biopha.2023.114426 ↗
31. 10.1016/j.intimp.2025.11500910.1016/j.intimp.2025.115009 ↗
32. 10.1002/mco2.7030410.1002/mco2.70304 ↗
33. 10.1111/iep.1248910.1111/iep.12489 ↗
34. 10.1080/08820139.2024.243469210.1080/08820139.2024.2434692 ↗
35. 10.1016/j.critrevonc.2025.10481310.1016/j.critrevonc.2025.104813 ↗
36. 10.1016/j.ejphar.2025.17798410.1016/j.ejphar.2025.177984 ↗
37. 10.1016/j.prp.2025.15611110.1016/j.prp.2025.156111 ↗
38. 10.1016/j.prp.2025.15609210.1016/j.prp.2025.156092 ↗
39. 10.1016/j.bbrc.2025.15203310.1016/j.bbrc.2025.152033 ↗
40. 10.1002/jcp.2502610.1002/jcp.25026 ↗
41. 10.1016/j.phymed.2016.09.01110.1016/j.phymed.2016.09.011 ↗
42. 10.3892/ijmm.2014.165810.3892/ijmm.2014.1658 ↗
43. 10.1371/journal.pone.004751610.1371/journal.pone.0047516 ↗
44. 10.1007/s12672-024-00909-110.1007/s12672-024-00909-1 ↗
45. 10.1016/j.phymed.2022.15457210.1016/j.phymed.2022.154572 ↗